Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biomarker Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Consumables
1.2.3 Service
1.3 Market by Application
1.3.1 Global Biomarker Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Diagnostics Development
1.3.3 Drug Discovery and Development
1.3.4 Disease-Risk
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biomarker Market Perspective (2018-2033)
2.2 Biomarker Growth Trends by Region
2.2.1 Global Biomarker Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Biomarker Historic Market Size by Region (2018-2023)
2.2.3 Biomarker Forecasted Market Size by Region (2024-2033)
2.3 Biomarker Market Dynamics
2.3.1 Biomarker Industry Trends
2.3.2 Biomarker Market Drivers
2.3.3 Biomarker Market Challenges
2.3.4 Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biomarker Players by Revenue
3.1.1 Global Top Biomarker Players by Revenue (2018-2023)
3.1.2 Global Biomarker Revenue Market Share by Players (2018-2023)
3.2 Global Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biomarker Revenue
3.4 Global Biomarker Market Concentration Ratio
3.4.1 Global Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biomarker Revenue in 2022
3.5 Biomarker Key Players Head office and Area Served
3.6 Key Players Biomarker Product Solution and Service
3.7 Date of Enter into Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biomarker Breakdown Data by Type
4.1 Global Biomarker Historic Market Size by Type (2018-2023)
4.2 Global Biomarker Forecasted Market Size by Type (2024-2033)
5 Biomarker Breakdown Data by Application
5.1 Global Biomarker Historic Market Size by Application (2018-2023)
5.2 Global Biomarker Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Biomarker Market Size (2018-2033)
6.2 North America Biomarker Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Biomarker Market Size by Country (2018-2023)
6.4 North America Biomarker Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biomarker Market Size (2018-2033)
7.2 Europe Biomarker Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Biomarker Market Size by Country (2018-2023)
7.4 Europe Biomarker Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biomarker Market Size (2018-2033)
8.2 Asia-Pacific Biomarker Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Biomarker Market Size by Region (2018-2023)
8.4 Asia-Pacific Biomarker Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biomarker Market Size (2018-2033)
9.2 Latin America Biomarker Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Biomarker Market Size by Country (2018-2023)
9.4 Latin America Biomarker Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biomarker Market Size (2018-2033)
10.2 Middle East & Africa Biomarker Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Biomarker Market Size by Country (2018-2023)
10.4 Middle East & Africa Biomarker Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd.
11.1.1 F. Hoffmann-La Roche Ltd. Company Detail
11.1.2 F. Hoffmann-La Roche Ltd. Business Overview
11.1.3 F. Hoffmann-La Roche Ltd. Biomarker Introduction
11.1.4 F. Hoffmann-La Roche Ltd. Revenue in Biomarker Business (2018-2023)
11.1.5 F. Hoffmann-La Roche Ltd. Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Biomarker Introduction
11.2.4 Abbott Revenue in Biomarker Business (2018-2023)
11.2.5 Abbott Recent Development
11.3 Epigenomics AG
11.3.1 Epigenomics AG Company Detail
11.3.2 Epigenomics AG Business Overview
11.3.3 Epigenomics AG Biomarker Introduction
11.3.4 Epigenomics AG Revenue in Biomarker Business (2018-2023)
11.3.5 Epigenomics AG Recent Development
11.4 General Electric
11.4.1 General Electric Company Detail
11.4.2 General Electric Business Overview
11.4.3 General Electric Biomarker Introduction
11.4.4 General Electric Revenue in Biomarker Business (2018-2023)
11.4.5 General Electric Recent Development
11.5 Johnson & Johnson Services, Inc.
11.5.1 Johnson & Johnson Services, Inc. Company Detail
11.5.2 Johnson & Johnson Services, Inc. Business Overview
11.5.3 Johnson & Johnson Services, Inc. Biomarker Introduction
11.5.4 Johnson & Johnson Services, Inc. Revenue in Biomarker Business (2018-2023)
11.5.5 Johnson & Johnson Services, Inc. Recent Development
11.6 Thermo Fisher Scientific Inc.
11.6.1 Thermo Fisher Scientific Inc. Company Detail
11.6.2 Thermo Fisher Scientific Inc. Business Overview
11.6.3 Thermo Fisher Scientific Inc. Biomarker Introduction
11.6.4 Thermo Fisher Scientific Inc. Revenue in Biomarker Business (2018-2023)
11.6.5 Thermo Fisher Scientific Inc. Recent Development
11.7 Bio-Rad Laboratories, Inc.
11.7.1 Bio-Rad Laboratories, Inc. Company Detail
11.7.2 Bio-Rad Laboratories, Inc. Business Overview
11.7.3 Bio-Rad Laboratories, Inc. Biomarker Introduction
11.7.4 Bio-Rad Laboratories, Inc. Revenue in Biomarker Business (2018-2023)
11.7.5 Bio-Rad Laboratories, Inc. Recent Development
11.8 Siemens Healthcare GmbH
11.8.1 Siemens Healthcare GmbH Company Detail
11.8.2 Siemens Healthcare GmbH Business Overview
11.8.3 Siemens Healthcare GmbH Biomarker Introduction
11.8.4 Siemens Healthcare GmbH Revenue in Biomarker Business (2018-2023)
11.8.5 Siemens Healthcare GmbH Recent Development
11.9 QIAGEN
11.9.1 QIAGEN Company Detail
11.9.2 QIAGEN Business Overview
11.9.3 QIAGEN Biomarker Introduction
11.9.4 QIAGEN Revenue in Biomarker Business (2018-2023)
11.9.5 QIAGEN Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Biomarker Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Consumables
Table 3. Key Players of Service
Table 4. Global Biomarker Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Biomarker Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Biomarker Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Biomarker Market Share by Region (2018-2023)
Table 8. Global Biomarker Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Biomarker Market Share by Region (2024-2033)
Table 10. Biomarker Market Trends
Table 11. Biomarker Market Drivers
Table 12. Biomarker Market Challenges
Table 13. Biomarker Market Restraints
Table 14. Global Biomarker Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Biomarker Market Share by Players (2018-2023)
Table 16. Global Top Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomarker as of 2022)
Table 17. Ranking of Global Top Biomarker Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Biomarker Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Biomarker Product Solution and Service
Table 21. Date of Enter into Biomarker Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Biomarker Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Biomarker Revenue Market Share by Type (2018-2023)
Table 25. Global Biomarker Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Biomarker Revenue Market Share by Type (2024-2033)
Table 27. Global Biomarker Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Biomarker Revenue Market Share by Application (2018-2023)
Table 29. Global Biomarker Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Biomarker Revenue Market Share by Application (2024-2033)
Table 31. North America Biomarker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Biomarker Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Biomarker Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Biomarker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Biomarker Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Biomarker Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Biomarker Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Biomarker Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Biomarker Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Biomarker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Biomarker Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Biomarker Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Biomarker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Biomarker Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Biomarker Market Size by Country (2024-2033) & (US$ Million)
Table 46. F. Hoffmann-La Roche Ltd. Company Detail
Table 47. F. Hoffmann-La Roche Ltd. Business Overview
Table 48. F. Hoffmann-La Roche Ltd. Biomarker Product
Table 49. F. Hoffmann-La Roche Ltd. Revenue in Biomarker Business (2018-2023) & (US$ Million)
Table 50. F. Hoffmann-La Roche Ltd. Recent Development
Table 51. Abbott Company Detail
Table 52. Abbott Business Overview
Table 53. Abbott Biomarker Product
Table 54. Abbott Revenue in Biomarker Business (2018-2023) & (US$ Million)
Table 55. Abbott Recent Development
Table 56. Epigenomics AG Company Detail
Table 57. Epigenomics AG Business Overview
Table 58. Epigenomics AG Biomarker Product
Table 59. Epigenomics AG Revenue in Biomarker Business (2018-2023) & (US$ Million)
Table 60. Epigenomics AG Recent Development
Table 61. General Electric Company Detail
Table 62. General Electric Business Overview
Table 63. General Electric Biomarker Product
Table 64. General Electric Revenue in Biomarker Business (2018-2023) & (US$ Million)
Table 65. General Electric Recent Development
Table 66. Johnson & Johnson Services, Inc. Company Detail
Table 67. Johnson & Johnson Services, Inc. Business Overview
Table 68. Johnson & Johnson Services, Inc. Biomarker Product
Table 69. Johnson & Johnson Services, Inc. Revenue in Biomarker Business (2018-2023) & (US$ Million)
Table 70. Johnson & Johnson Services, Inc. Recent Development
Table 71. Thermo Fisher Scientific Inc. Company Detail
Table 72. Thermo Fisher Scientific Inc. Business Overview
Table 73. Thermo Fisher Scientific Inc. Biomarker Product
Table 74. Thermo Fisher Scientific Inc. Revenue in Biomarker Business (2018-2023) & (US$ Million)
Table 75. Thermo Fisher Scientific Inc. Recent Development
Table 76. Bio-Rad Laboratories, Inc. Company Detail
Table 77. Bio-Rad Laboratories, Inc. Business Overview
Table 78. Bio-Rad Laboratories, Inc. Biomarker Product
Table 79. Bio-Rad Laboratories, Inc. Revenue in Biomarker Business (2018-2023) & (US$ Million)
Table 80. Bio-Rad Laboratories, Inc. Recent Development
Table 81. Siemens Healthcare GmbH Company Detail
Table 82. Siemens Healthcare GmbH Business Overview
Table 83. Siemens Healthcare GmbH Biomarker Product
Table 84. Siemens Healthcare GmbH Revenue in Biomarker Business (2018-2023) & (US$ Million)
Table 85. Siemens Healthcare GmbH Recent Development
Table 86. QIAGEN Company Detail
Table 87. QIAGEN Business Overview
Table 88. QIAGEN Biomarker Product
Table 89. QIAGEN Revenue in Biomarker Business (2018-2023) & (US$ Million)
Table 90. QIAGEN Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biomarker Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Biomarker Market Share by Type: 2022 VS 2033
Figure 3. Consumables Features
Figure 4. Service Features
Figure 5. Global Biomarker Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Biomarker Market Share by Application: 2022 VS 2033
Figure 7. Diagnostics Development Case Studies
Figure 8. Drug Discovery and Development Case Studies
Figure 9. Disease-Risk Case Studies
Figure 10. Other Case Studies
Figure 11. Biomarker Report Years Considered
Figure 12. Global Biomarker Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Biomarker Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Biomarker Market Share by Region: 2022 VS 2033
Figure 15. Global Biomarker Market Share by Players in 2022
Figure 16. Global Top Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomarker as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Biomarker Revenue in 2022
Figure 18. North America Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Biomarker Market Share by Country (2018-2033)
Figure 20. United States Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Biomarker Market Share by Country (2018-2033)
Figure 24. Germany Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Biomarker Market Share by Region (2018-2033)
Figure 32. China Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Biomarker Market Share by Country (2018-2033)
Figure 40. Mexico Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Biomarker Market Share by Country (2018-2033)
Figure 44. Turkey Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Biomarker Business (2018-2023)
Figure 47. Abbott Revenue Growth Rate in Biomarker Business (2018-2023)
Figure 48. Epigenomics AG Revenue Growth Rate in Biomarker Business (2018-2023)
Figure 49. General Electric Revenue Growth Rate in Biomarker Business (2018-2023)
Figure 50. Johnson & Johnson Services, Inc. Revenue Growth Rate in Biomarker Business (2018-2023)
Figure 51. Thermo Fisher Scientific Inc. Revenue Growth Rate in Biomarker Business (2018-2023)
Figure 52. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Biomarker Business (2018-2023)
Figure 53. Siemens Healthcare GmbH Revenue Growth Rate in Biomarker Business (2018-2023)
Figure 54. QIAGEN Revenue Growth Rate in Biomarker Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed